Solriamfetol effective for managing ADHD in adults
Oct 17, 2023
Solriamfetol was found to be well-tolerated with no significant effect on mean heart rate or systolic or diastolic blood pressure.
Medication managed by AI can help patients feel better, study shows
By
Aaron Dorman
Aug 02, 2023
New research on an AI-tool for medication management showed cost savings and effective decision-making for high-risk patients.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Telehealth giants pairing obesity drugs with weight-loss programs to prevent overreliance on prescriptions
By
Aaron Dorman
Aug 23, 2023
Telehealth companies could offer, or even require, virtual fitness program pairing with obesity drugs, as new procedures are developed.
Med-management software company releases new tool for nursing facilities to meet new need for CMS compliance
By
Aaron Dorman
Sep 20, 2023
To meet new CMS rules for nursing homes, one company is releasing a new service that focuses on ensuring a patient’s medication listings are up-to-date.
Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
Senate hearing, OIG report target substance use disorders
By
Kimberly Marselas
Feb 01, 2024
Both reveal that older adults need more help than ever when it comes to getting the treatment they need to address such issues.
AI helps prevent prescription dosing errors
By
Christine Birkner
Jun 02, 2023
Software company DrFirst developed an AI-powered tool to streamline medication refill and renewal requests.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.